Recent Updates
|
Charter
Meaningful Use Stage 1 and foreseen Stage 2 requires information to be exchanged in transition of care. Implementers are often confused on how to use the specifications to exchange the required data. The exchange of clinical summaries is hampered by ambiguous common definitions of what data elements must at a minimum be exchanged, how they must be encoded, and how those common semantic elements map to MU specified formats (C32/CCD and CCR). Finally, the lack of a robust toolset to aid in development and validation of conformant templated clinical documents is a major impediment to the widespread adoption of the standards
Purpose and Goals
Meaningful Use: Exchange key clinical information among providers of care and with patients and other authorized entities electronically based on level of system capability, i.e., human readable, unstructured text or full interoperable structured data
- Enable Clinical Summary validation services to be available such that if an organization passes validation, they have a high degree of confidence that any other organization passing the same validation has a 99.9% opportunity to understand the same core clinical information whether as unstructured data or structured and encoded data.
- Reduce template development time through new tools and process developed through the S&I Framework and public/private activities (such as Open Health Tools) by a factor of 1.5x. Reduce time to create a new unstructured and structured documents based on the HL7 CDA by 10% in 2011 and by 25% in 2013
Scope
The Scope of this Initiative is as its first priority support for Meaningful Use Stage 1 summary of care (Eligible Provider, Eligible Hospital, and Critical Access Hospital) requirements for transition of care and transition of care to consumer and as a second priority support for expected Stage 2 requirements.
Success Metrics
| Outcome Metrics |
|
|---|---|
| Process Metrics |
|
Timeline

Schedule
- Transition of Care Project Kickoff Meeting - Monday, January 31st - 2pm ET.
- Telecom Occurs every Wednesday effective 2/9/2011 until 12/28/2011 from 3:00 PM to 4:30 PM (ET).
- Dial: 1-866-816-4209, Access Code: 3980879
- https://www3.gotomeeting.com/join/170251710/106565419
Members
Transition of Care initiative stakeholders come from across the health care IT industry to make up the Transition of Care Initiative Members.
About our Workgroups
Note: Initiative members will determine necessary workgroups with launch of initiative. Below are an initial list of proposed Workgroups by the Initiative Coordinators.
Committed members participate in at least one of the following workgroups under the Transition of Care project:
| Workgroup | WG Lead | WG Support Leads | Description |
|---|---|---|---|
| Use Case & Requirements | TBD | Amy Berk RN, MSN Ed Larsen |
Focused on identifying and developing the relevant use cases and functional requirements supporting the business needs for exchange and interoperability |
| Vocabulary | TBD | Focused on communication/expression of specifications in CCR and CDA | |
| Harmonization | TBD |
Documents differences in C83 and CCR |
The Transition of Care project is coordinated by Arien Malec with the guidance of the Office of Interoperability and Standards (OIS) under the Office of National Coordinator.
How to Get Involved
- Keep me Informed
- To be notified about significant events and announcements from the project, follow this site
- How can I contribute?
- Visit the "Getting Started as a Volunteer" page
- Review the existing Lab Interface project's workgroups to see where you can contribute
- Refrain from defacement, abuse, commercial promotion, or other content that violates our Wiki Use Guidelines
- Add my organization as an official member
- Submit a Statement of Commitment on behalf of your organization
- For more information, also contact admin@siframework.com


1 Comment
comments.show.hideFeb 23, 2011
dtao
Hello! Doug Pratt is the primary Siemens representative to this initiative, but I will be attending today's call. I have a question/suggestion about one of the Outcome Metrics which, to me, seems misworded.
"2. Number of organizations who have been certified to produce valid specifications (Software development/Tools organizations/Provider organizations)"
There aren't many organizations actually producing specifications (this initiative is one of them, as well as HL7, IHE, etc.). Shouldn't the objective say instead:
"2. Number of organizations who have been certified to produce valid ToC Clinical Summaries conforming to the ToC specifications (Software development/Tools organizations/Provider organizations)"
?
Thanks,
David Tao